Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech Oct 19 (Reuters) - Hong Kong-listed Metis TechBio 7666.HK on Monday said it has entered a collaboration agreement with Eli Lilly LLY.N worth up to $1.1 billion for the research and development of tissue-specific drug delivery technologies.
(Reporting by Nikita Maria Jino in Bengaluru; Editing by Joyjeet Das)
Recent news on Eli Lilly and
See all newsUS stocks weekly: Spooky
Street View: Next-generation drugs bolster Lilly's growth outlook
US STOCKS-Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
US STOCKS-Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
US STOCKS-Wall Street slides as Alphabet revenue miss revives AI capex jitters